Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

Marcellin, P.; Ahn, S. H.; Chuang, W.‐L-L.; Hui, A. J.; Tabak, F.; Mehta, R.; Petersen, J.; Lee, C.‐M-M.; Ma, X.; Caruntu, F. A.; Tak, W. Y.; Elkhashab, M.; Lin, L.; Wu, G.; Martins, E. B.; Charuworn, P.; Yee, L. J.; Lim, S. G.; Foster, G. R.; Fung, S.; Morano, L.; Samuel, D.; Agarwal, K.; Idilman, R.; Strasser, S. I.; Buti, M.; Gaeta, G. B.; Papatheodoridis, G.; Flisiak, R.; Chan, H. L. Y.

Published in

Wiley, Alimentary Pharmacology and Therapeutics, 9(44), p. 957-966, 2016

DOI: 10.1111/apt.13779

Tools

Export citation

Search in Google Scholar

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

Journal article published in 2016 by P. Marcellin, S. H. Ahn, W.‐L-L. Chuang, A. J. Hui, F. Tabak, R. Mehta, J. Petersen, C.‐M-M. Lee, X. Ma, F. A. Caruntu, W. Y. Tak, M. Elkhashab, L. Lin, G. Wu, E. B. Martins and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B